CDKN2B-AS1 has been confirmed to be upregulated in a variety of tumor tissues (34–39), which is involved in the processes of tumor cell proliferation, migration, invasion, and inhibition of tumor cell apoptosis. This evidence concerns the gene CDKN2B and neoplasm.